Search Results - "ORTNER, Marianne"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study by Ortner, Marianne E.J, Caca, Karel, Berr, Frieder, Liebetruth, Jochen, Mansmann, Ulrich, Huster, Dominik, Voderholzer, Winfried, Schachschal, Guido, Mössner, Joachim, Lochs, Herbert

    Published in Gastroenterology (New York, N.Y. 1943) (01-11-2003)
    “…In nonrandomized trials, photodynamic therapy (PDT) had a promising effect on nonresectable cholangiocarcinoma (NCC). This prospective, open-label, randomized,…”
    Get full text
    Journal Article
  2. 2

    Association between intraepithelial Escherichia coli and colorectal cancer by Swidsinski, Alexander, Khilkin, Michael, Kerjaschki ‡, Dontscho, Schreiber, Stefan, Ortner, Marianne, Weber, Jutta, Lochs, Herbert

    Published in Gastroenterology (New York, N.Y. 1943) (01-08-1998)
    “…Background & Aims: Although multiple studies have focused on Helicobacter pylori, little is known about the mucosa-associated flora of the colon. The aim of…”
    Get full text
    Journal Article
  3. 3

    Promoter Methylation of INK4a/ARF As Detected in Bile-Significance for the Differential Diagnosis in Biliary Disease by KLUMP, Bodo, HSIEH, Chih-Jen, DETTE, Stephan, HOLZMANN, Karlheinz, KIESSLICH, Ralf, JUNG, Michael, SINN, Udo, ORTNER, Marianne, PORSCHEN, Rainer, GREGOR, Michael

    Published in Clinical cancer research (01-05-2003)
    “…Purpose: There is a need to enhance endobiliary cytotechniques by molecular marker lesions. This is of special significance for patients with primary…”
    Get full text
    Journal Article
  4. 4

    Photodynamic therapy for cholangiocarcinoma by Ortner, Marianne

    “…The prognosis of nonresectable cholangiocarcinoma is dismal, and in Bismuth type III and IV tumors relief of jaundice is seldom achieved, despite successful…”
    Get full text
    Journal Article
  5. 5

    Mucosal flora in inflammatory bowel disease by Swidsinski, Alexander, Ladhoff, Axel, Pernthaler, Annelie, Swidsinski, Sonja, Loening-Baucke, Vera, Ortner, Marianne, Weber, Jutta, Hoffmann, Uwe, Schreiber, Stefan, Dietel, Manfred, Lochs, Herbert

    Published in Gastroenterology (New York, N.Y. 1943) (01-01-2002)
    “…Microorganisms that directly interact with the intestinal mucosa are obscured by fecal flora and poorly characterized. We investigated the mucosal flora of…”
    Get full text
    Journal Article
  6. 6

    Cancer prevention in ulcerative colitis: Long‐term outcome following fluorescence‐guided colonoscopy by Fusco, Virginia, Ebert, Bernd, Weber‐Eibel, Jutta, Jost, Christian, Fleige, Barbara, Stolte, Manfred, Oberhuber, Georg, Rinneberg, Herbert, Lochs, Herbert, Ortner, Marianne

    Published in Inflammatory bowel diseases (01-03-2012)
    “…Background: Patients with long‐standing ulcerative colitis require repeated endoscopies for early detection of neoplasias, which, however, are frequently…”
    Get full text
    Journal Article
  7. 7

    Wireless capsule pH monitoring: does it fulfil all expectations? by Maerten, Philippe, Ortner, Marianne, Michetti, Pierre, Dorta, Gian

    Published in Digestion (01-01-2007)
    “…pH monitoring has been used as a diagnostic tool in gastro-oesophageal reflux disease (GERD) for many years. Recent studies have shown that wireless capsule pH…”
    Get more information
    Journal Article
  8. 8

    Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study by Ortner, M -A, Zumbusch, K, Liebetruth, J, Ebert, B, Fleige, B, Dietel, M, Lochs, H

    Published in Endoscopy (01-08-2002)
    “…The methods of endoscopic ablation of metaplastic and dysplastic areas in Barrett's esophagus so far described, are not satisfactory with respect to efficacy…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Photodynamic therapy in the biliary tract by Ortner, M

    Published in Current gastroenterology reports (01-04-2001)
    “…Biliary tract cancers are rare malignancies usually characterized by slow growth and a low propensity for metastasis. Despite the relatively localized nature…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18